Tumour thickness as a predictor of occult lymph node metastases in patients with stage I and II melanoma undergoing sentinel lymph node biopsy.

PubWeight™: 0.97‹?› | Rank: Top 15%

🔗 View Article (PMID 12296887)

Published in Br J Surg on October 01, 2002

Authors

M B Lens1, M Dawes, J A Newton-Bishop, T Goodacre

Author Affiliations

1: University of Oxford, Centre for Evidence-Based Medicine, Nuffield Department of Clinical Medicine and Department for Plastic and Reconstructive Surgery, The Oxford Radcliffe NHS Trust, Oxford, UK.

Articles by these authors

Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol (2004) 5.49

Patients' health related quality of life before and after aesthetic surgery. Br J Plast Surg (1996) 3.81

Should breast reduction surgery be rationed? A comparison of the health status of patients before and after treatment: postal questionnaire survey. BMJ (1996) 2.92

Cutaneous adverse events associated with vemurafenib in patients with metastatic melanoma: practical advice on diagnosis, prevention and management of the main treatment-related skin toxicities. Br J Dermatol (2012) 2.23

Revised U.K. guidelines for the management of cutaneous melanoma 2010. Br J Dermatol (2010) 2.22

Global medical knowledge database is proposed. BMJ (2000) 2.21

Etiology of early age onset substance use disorder: a maturational perspective. Dev Psychopathol (1999) 2.16

GP frequent consulters: their prevalence, natural history, and contribution to rising workload. Br J Gen Pract (1998) 1.78

Measuring quality of life in cosmetic surgery patients with a condition-specific instrument: the Derriford Scale. Br J Plast Surg (1998) 1.60

Recent trends in cutaneous malignant melanoma in the Yorkshire region of England; incidence, mortality and survival in relation to stage of disease, 1993-2003. Br J Cancer (2006) 1.33

Desmoplastic malignant melanoma: a systematic review. Br J Dermatol (2005) 1.27

Revised UK guidelines for the management of cutaneous melanoma 2010. J Plast Reconstr Aesthet Surg (2010) 1.16

Naevi and pigmentary characteristics as risk factors for melanoma in a high-risk population: a case-control study in New South Wales, Australia. Int J Cancer (1996) 1.15

Survey of U.K. current practice in the treatment of lentigo maligna. Br J Dermatol (2001) 1.12

Presentation, management and course of angina and suspected angina in primary care. J Psychosom Res (1999) 1.10

Melanoma sentinel node biopsy and prediction models for relapse and overall survival. Br J Cancer (2010) 0.99

Evidence based case report: chlamydia infection in general practice. BMJ (1999) 0.96

Systematic reviews of clinical decision tools for acute abdominal pain. Health Technol Assess (2006) 0.92

Cutaneous granulomas associated with primary immunodeficiency disorders. Br J Dermatol (2005) 0.87

An association between cutaneous melanoma and non-Hodgkin's lymphoma: pooled analysis of published data with a review. Ann Oncol (2005) 0.86

Contrasting evidence of the effectiveness of cosmetic surgery from two health related quality of life measures. J Epidemiol Community Health (1999) 0.85

Within-patient correlation between the antihypertensive effects of atenolol, lisinopril and nifedipine. J Hypertens (1994) 0.83

Evidence-based medicine. Br J Gen Pract (2000) 0.81

A human monoclonal antibody encoded by the V4-34 gene segment recognises melanoma-associated ganglioside via CDR3 and FWR1. Hum Antibodies (1999) 0.80

Methods of assessing health-related quality of life and outcome for plastic surgery. Br J Plast Surg (1999) 0.78

Plasma osteopontin concentrations in patients with cutaneous melanoma. Oncol Rep (2013) 0.77

Anticoagulation-associated upper gastrointestinal haemorrhage. Intern Med J (2013) 0.76

Danazol treatment and acute myocardial infarction. J Obstet Gynaecol (2003) 0.76

A retrospective study addressed to understanding what predicts severe histological dysplasia/early melanoma in excised atypical melanocytic lesions. Br J Dermatol (2007) 0.76

Randomised controlled trials in general practice. Internal validity of trials is more important than generalisability. BMJ (1996) 0.76

Quality of life following resection, free flap reconstruction and postoperative external beam radiotherapy for squamous cell carcinoma of the base of tongue. Clin Otolaryngol Allied Sci (2004) 0.75

A child with laryngo-onychocutaneous syndrome partially responsive to treatment with thalidomide. Br J Dermatol (2006) 0.75

Second primary melanomas on treatment with vemurafenib: reply from the authors. Br J Dermatol (2013) 0.75

Management of infants with Pierre Robin sequence. Cleft Palate Craniofac J (2004) 0.75

Day surgery and community health services work load: a descriptive study. Br J Gen Pract (1996) 0.75

Fever six weeks after trauma. J R Soc Med (2003) 0.75

Validation of a rapid whole blood test for diagnosing Helicobacter pylori infection. Likelihood ratios should be routinely reported. BMJ (1997) 0.75

How to assess endothelial function in human blood vessels. J Hypertens (2000) 0.75

Angiotensin II, but not aldosterone and renin, correlates positively with increased concentrations of N-terminal pro-brain natriuretic peptide in patients with chronic heart failure. Heart (2005) 0.75

Evidence for double resistance to permethrin and malathion in head lice. Br J Dermatol (2000) 0.75

Quality-of-life outcomes after cosmetic surgery. Plast Reconstr Surg (1999) 0.75

Training of overseas qualified doctors in Britain. Training programmes in countries overseas should be supported. BMJ (1996) 0.75

Re: Breast Reduction Outcome Study. Ann Plast Surg (2000) 0.75

A case of Bazex-Dupré-Christol syndrome associated with multiple genital trichoepitheliomas. Br J Dermatol (2005) 0.75

Management of regional lymph nodes in patients with malignant melanoma: questionnaire survey of UK current practice. Br J Plast Surg (2002) 0.75

Peaceful means. Nurs Stand (1997) 0.75

Evidence-based medicine: science and art. Can Fam Physician (2001) 0.75

The twist drain. Ann R Coll Surg Engl (1988) 0.75

The Derriford Appearance Scale (DAS-59). Br J Plast Surg (2001) 0.75

An exploration of reported mortality from cutaneous squamous cell carcinoma using death certification and cancer registry data. Br J Dermatol (2013) 0.75

Cleft lip and palate. Trop Doct (2002) 0.75